SCOPUS 정보 검색 플랫폼

Volumn 36, Issue 1, 2002, Pages 186-194

Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B

(11) Perrillo, Robert P a Lai, Ching Lung b Liaw, Yun Fan c Dienstag, Jules L d Schiff, Eugene R e Schalm, Solko W f Heathcote, E Jenny g Brown, Nathaniel A h Atkins, Mark i Woessner, Mary j Gardner, Stephen D j

a OCHSNER CLINIC FOUNDATION (United States)

b QUEEN MARY HOSPITAL (Hong Kong)

c CHANG GUNG UNIVERSITY (Taiwan)

d MASSACHUSETTS GENERAL HOSPITAL (United States)

e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE (United States)

f ERASMUS MEDICAL CENTER (Netherlands)

g TORONTO WESTERN HOSPITAL (Canada)

h Novirio Pharmaceuticals Inc (United States)

i GLAXOSMITHKLINE (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; INTERFERON; LAMIVUDINE; PLACEBO;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASIAN; CAUCASIAN; CHRONIC HEPATITIS; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE COURSE; DRUG RESPONSE; FEMALE; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 18444367980 PISSN: 02709139 EISSN: None Source Type: Journal
DOI: 10.1053/jhep.2002.34294 Document Type: Article

Times cited : (294)

References (25)

1
- 0000532607
- Epidemiology of viral hepatitis: An overview
- (1993) Sem Virol , vol.4 , pp. 273-283
- Mast, E.E.¹ Alter, M.J.²

2
- 0023771584
- Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis B
- (1988) Gastroenterology , vol.95 , pp. 1318-1325
- Hoofnagle, J.H.¹ Peters, M.² Mullen, K.D.³ Jones, D.B.⁴ Rustgi, V.⁵ Di Bisceglie, A.⁶ Hallahan, C.⁷

3
- 0025347975
- A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B
- (1990) N Engl J Med , vol.323 , pp. 295-301
- Perrillo, R.P.¹ Schiff, E.R.² Davis, G.L.³ Bodenheimer, H.C.⁴ Lindsay, K.⁵ Payne, J.⁶ Dienstag, J.L.⁷

4
- 0029591574
- A preliminary trial of lamivudine for chronic hepatitis B infection
- (1995) N Engl J Med , vol.333 , pp. 1657-1661
- Dienstag, J.L.¹ Perrillo, R.P.² Schiff, E.R.³ Bartholomew, M.⁴ Vicary, C.⁵ Rubin, M.⁶

5
- 0031021902
- Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: A placebo-controlled trial
- (1997) Hepatology , vol.25 , pp. 241-244
- Lai, C.-L.¹ Ching, C.-K.² Tung, A.K.-M.³ Li, E.⁴ Young, J.⁵ Hill, A.⁶ Wong, B.C.⁷

6
- 0030772798
- Lamivudine therapy for chronic hepatitis B: A six month randomized dose-ranging study
- (1997) Gastroenterology , vol.113 , pp. 1258-1263
- Nevens, F.¹ Main, J.² Honkoop, P.³ Tyrrell, D.L.⁴ Barber, J.⁵ Sullivan, M.T.⁶ Fevery, J.⁷

7
- 0032499913
- A one-year trial of lamivudine for chronic hepatitis B
- (1998) N Engl J Med , vol.339 , pp. 61-68
- Lai, C.-L.¹ Chien, R.-N.² Leung, N.W.Y.³ Chang, T.-T.⁴ Guan, R.⁵ Tai, D.-I.⁶ Ng, K.Y.⁷

8
- 0033592764
- Lamivudine as initial treatment for chronic hepatitis B in the United States
- (1999) N Engl J Med , vol.341 , pp. 1256-1263
- Dienstag, J.L.¹ Schiff, E.R.² Wright, T.L.³ Perrillo, R.P.⁴ Hann, H.-W.⁵ Goodman, Z.⁶ Crowther, L.⁷

9
- 0001279724
- A placebo controlled study of lamivudine and interferon alpha-2b in patients with chronic hepatitis B who previously failed interferon therapy
- (1998) Hepatology , vol.28 , pp. 388A
- Schiff, E.¹ Karayalcin, S.² Grimm, I.³ Perrillo, R.P.⁴ Dienstag, J.L.⁵ Husa, P.⁶ Schalm, S.⁷

10
- 0034105307
- Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: A randomized trial
- (2000) Gut , vol.46 , pp. 562-568
- Schalm, S.W.¹ Heathcote, J.² Cianciara, J.³ Farrell, G.⁴ Sherman, M.⁵ Willems, B.⁶ Dhillon, A.⁷

11
- 0035010523
- Management of hepatitis B: 2000-Summary of a workshop
- (2001) Gastroenterology , vol.120 , pp. 1828-1853
- Lok, A.¹ Heathcote, J.² Hoofnagle, J.³

12
- 0029893146
- Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B
- (1996) N Engl J Med , vol.334 , pp. 1422-1427
- Niederau, C.¹ Heintges, T.² Lange, S.³ Goldmann, G.⁴ Niederau, C.M.⁵ Mohr, L.⁶ Haussinger, D.⁷

13
- 0030730879
- Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa
- (1997) Gastroenterology , vol.113 , pp. 1660-1667
- Lau, D.T.¹ Everhart, J.² Kleiner, D.E.³ Park, Y.⁴ Vergalla, J.⁵ Schmid, P.⁶ Hoofnagle, J.H.⁷

14
- 0025734569
- Long-term remission of chronic hepatitis B after alpha-interferon therapy
- (1991) Ann Intern Med , vol.114 , pp. 629-634
- Korenman, J.¹ Baker, B.² Waggoner, J.³ Everhart, J.E.⁴ Di Bisceglie, A.M.⁵ Hoofnagle, J.H.⁶

15
- 0024448926
- Which patients with chronic hepatitis B virus infection will respond to α-interferon therapy? A statistical analysis of predictive factors
- (1989) Hepatology , vol.10 , pp. 761-763
- Brook, M.G.¹ Karayiannis, P.² Thomas, H.C.³

16
- 0028887880
- Interferon alfa for chronic active hepatitis B. Long-term follow-up of 62 patients: Outcomes and predictors of response
- (1995) Med J Aust , vol.162 , pp. 8-11
- Hope, A.H.¹ Craig, P.I.² Grierson, J.M.³ Bilous, M.⁴ Williams, S.J.⁵ Farrell, G.C.⁶

17
- 0026602420
- A controlled trial of interferon with or without prednisone priming for chronic hepatitis B
- (1992) Gastroenterology , vol.102 , pp. 2091-2097
- Lok, A.S.F.¹ Wu, P.-C.² Lai, C.-L.³ Lau, J.Y.N.⁴ Leung, E.K.Y.⁵ Wong, L.S.K.⁶ Ma, O.C.⁷

18
- 0032869876
- Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B
- (1999) Hepatology , vol.30 , pp. 770-774
- Chien, R.-N.¹ Liaw, Y.-F.² Atkins, M.³

19
- 0019813866
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
- (1981) Hepatology , vol.1 , pp. 431-435
- Knodell, R.G.¹ Ishak, K.G.² Black, W.C.³ Chen, T.S.⁴ Craig, R.⁵ Kaplowitz, N.⁶ Kiernan, T.W.⁷

20
- 0022523381
- Evolving concepts of the clinical and serologic consequences of hepatitis B virus infection
- (1986) Semin Liver Dis , vol.6 , pp. 11-22
- Seeff, L.B.¹ Koff, R.S.²

21
- 0023759015
- Long-term follow-up in a randomized controlled trial of recombinant alpha-interferon in Chinese patients with chronic hepatitis B infection
- (1988) Lancet , vol.2 , pp. 298-302
- Lok, A.S.F.¹ Wu, P.-C.² Lai, C.-L.³ Leung, E.K.Y.⁴

22
- 0032169470
- Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B
- (1998) J Clin Invest , vol.102 , pp. 968-975
- Boni, C.¹ Bertoletti, A.² Penna, A.³ Cavalli, A.⁴ Pilli, M.⁵ Urbani, S.⁶ Scognamiglio, P.⁷

23
- 0024816253
- Mechanisms of action of interferons
- (1989) Semin Liver Dis , vol.9 , pp. 235-239
- Peters, M.¹

24
- 0005275711
- Recombinant interferon alpha can induce rearrangement of T cell antigen receptor alpha genes and maturation to cytotoxicity in T lymphocytes clones in vitro
- (1986) Proc Natl Acad Sci U S A , vol.83 , pp. 4887-4889
- Chen, L.-K.¹ Mathieu-Mahul, D.² Bach, F.H.³ Dausset, J.⁴ Bensussan, A.⁵ Sasportes, M.⁶

25
- 0034993211
- Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion: Results after 3 years of therapy
- (2001) Hepatology , vol.33 , pp. 1527-1532
- Leung, N.W.Y.¹ Lai, C.-L.² Chang, T.-T.³ Guan, R.⁴ Lee, C.-M.⁵ Ng, K.-Y.⁶ Lim, S.-G.⁷

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.